Plasma bioactive adrenomedullin predicts mortality and need for dialysis in critical COVID-19
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Plasma bioactive adrenomedullin predicts mortality and need for dialysis in critical COVID-19 ; volume:14 ; number:1 ; day:11 ; month:10 ; year:2024 ; pages:1-12 ; date:12.2024
Scientific reports ; 14, Heft 1 (11.10.2024), 1-12, 12.2024
- Creator
-
Johnsson, Patrik
Sievert, Theodor
Didriksson, Ingrid
Friberg, Hans
Frigyesi, Attila
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-74380-x
- URN
-
urn:nbn:de:101:1-2412302059435.784108540674
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
20.01.2023, 7:53 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Johnsson, Patrik
- Sievert, Theodor
- Didriksson, Ingrid
- Friberg, Hans
- Frigyesi, Attila
- SpringerLink (Online service)
Other Objects (12)
Plasma neutrophil gelatinase-associated lipocalin independently predicts dialysis need and mortality in critical COVID-19
Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness
Troponin I at admission in the intensive care unit predicts the need of dialysis in septic patients
Associations of Plasma Bioactive Adrenomedullin Levels with Cardiovascular Risk Factors in BRCA1/2 Mutation Carriers
Adrenomedullin and tumour microenvironment
Bioactive adrenomedullin and interleukin-6 in COVID-19: potential biomarkers of acute kidney injury and critical illness
Pro-Adrenomedullin predicts 10-year all-cause mortality in community-dwelling patients: a prospective cohort study
Plasma bioactive adrenomedullin on intensive care unit admission is associated with acute respiratory distress syndrome: an observational study
Prognostic Value of Bioactive Adrenomedullin in Critically Ill Patients with COVID-19 in Germany: An Observational Cohort Study
Bioactive adrenomedullin a prognostic biomarker in patients with mild to moderate dyspnea at the emergency department: an observational study
Adrenomedullin: a vasodilator to treat sepsis?
Adrenomedullin in COVID-19 induced endotheliitis
Plasma neutrophil gelatinase-associated lipocalin independently predicts dialysis need and mortality in critical COVID-19
Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness
Troponin I at admission in the intensive care unit predicts the need of dialysis in septic patients
Associations of Plasma Bioactive Adrenomedullin Levels with Cardiovascular Risk Factors in BRCA1/2 Mutation Carriers
Adrenomedullin and tumour microenvironment
Bioactive adrenomedullin and interleukin-6 in COVID-19: potential biomarkers of acute kidney injury and critical illness
Pro-Adrenomedullin predicts 10-year all-cause mortality in community-dwelling patients: a prospective cohort study
Plasma bioactive adrenomedullin on intensive care unit admission is associated with acute respiratory distress syndrome: an observational study
Prognostic Value of Bioactive Adrenomedullin in Critically Ill Patients with COVID-19 in Germany: An Observational Cohort Study
Bioactive adrenomedullin a prognostic biomarker in patients with mild to moderate dyspnea at the emergency department: an observational study
Adrenomedullin: a vasodilator to treat sepsis?
Adrenomedullin in COVID-19 induced endotheliitis
Plasma neutrophil gelatinase-associated lipocalin independently predicts dialysis need and mortality in critical COVID-19
Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness
Troponin I at admission in the intensive care unit predicts the need of dialysis in septic patients
Associations of Plasma Bioactive Adrenomedullin Levels with Cardiovascular Risk Factors in BRCA1/2 Mutation Carriers
Adrenomedullin and tumour microenvironment
Bioactive adrenomedullin and interleukin-6 in COVID-19: potential biomarkers of acute kidney injury and critical illness
Pro-Adrenomedullin predicts 10-year all-cause mortality in community-dwelling patients: a prospective cohort study
Plasma bioactive adrenomedullin on intensive care unit admission is associated with acute respiratory distress syndrome: an observational study
Prognostic Value of Bioactive Adrenomedullin in Critically Ill Patients with COVID-19 in Germany: An Observational Cohort Study
Bioactive adrenomedullin a prognostic biomarker in patients with mild to moderate dyspnea at the emergency department: an observational study
Adrenomedullin: a vasodilator to treat sepsis?